Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis
暂无分享,去创建一个
Eric Westman | Tobias Granberg | Chunjie Guo | Daniel Ferreira | E. Westman | D. Ferreira | Chunjie Guo | T. Granberg | K. Fink | Katarina Fink
[1] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[2] F. Fazekas,et al. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis , 2012, Journal of Neurology.
[3] Eric Westman,et al. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy , 2014, Journal of Neuroimmunology.
[4] C Confavreux,et al. Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques , 2012, American Journal of Neuroradiology.
[5] Bruce Fischl,et al. FreeSurfer , 2012, NeuroImage.
[6] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[7] David H. Miller,et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.
[8] Bruce Fischl,et al. Within-subject template estimation for unbiased longitudinal image analysis , 2012, NeuroImage.
[9] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[10] Arvid Lundervold,et al. Evaluation of automated brain MR image segmentation and volumetry methods , 2009, Human brain mapping.
[11] O. Ciccarelli,et al. Nonconventional MRI and microstructural cerebral changes in multiple sclerosis , 2015, Nature Reviews Neurology.
[12] Ninon Burgos,et al. New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .
[13] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[14] Jeffrey A. Cohen,et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.
[15] John Ashburner,et al. A fast diffeomorphic image registration algorithm , 2007, NeuroImage.
[16] O. Ciccarelli,et al. MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES , 2016, The Lancet Neurology.
[17] Kuncheng Li,et al. Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS , 2017, European Radiology.
[18] Anders M. Dale,et al. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths , 2009, NeuroImage.
[19] P. Lundberg,et al. Novel whole brain segmentation and volume estimation using quantitative MRI , 2012, European Radiology.
[20] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[21] Bernhard Hemmer,et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis , 2012, NeuroImage.
[22] David H. Miller,et al. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials , 2009, Nature Reviews Neurology.
[23] Anders M. Dale,et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.
[24] P Aspelin,et al. Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study , 2016, American Journal of Neuroradiology.
[25] F. Barkhof,et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients , 2015, Nature Reviews Neurology.
[26] K Kazemi,et al. Quantitative Comparison of SPM, FSL, and Brainsuite for Brain MR Image Segmentation , 2014, Journal of biomedical physics & engineering.
[27] Amir Alansary,et al. MRBrainS Challenge: Online Evaluation Framework for Brain Image Segmentation in 3T MRI Scans , 2015, Comput. Intell. Neurosci..
[28] L. Lönn,et al. Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society , 2016, Acta neurologica Scandinavica.
[29] Mark W. Woolrich,et al. FSL , 2012, NeuroImage.
[30] Mehul P. Sampat,et al. Disease modeling in multiple sclerosis: Assessment and quantification of sources of variability in brain parenchymal fraction measurements , 2010, NeuroImage.
[31] Mark Jenkinson,et al. Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis , 2012, NeuroImage.
[32] M. Viergever,et al. Robustness of Automated Methods for Brain Volume Measurements across Different MRI Field Strengths , 2016, PloS one.
[33] Anisha Keshavan,et al. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis , 2016, NeuroImage.
[34] M. Battaglini,et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes , 2010, Neurology.
[35] Christian Gaser,et al. CAT-A Computational Anatomy Toolbox for the Analysis of Structural MRI Data , 2016 .
[36] Xavier Lladó,et al. Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling , 2015, NeuroImage: Clinical.
[37] M. Battaglini,et al. Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[38] David H. Miller,et al. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes , 2010, Journal of magnetic resonance imaging : JMRI.